Drug companies want to dismiss judge in federal opioid trial

Lawyers representing drug companies and pharmacies in the upcoming federal opioid trial filed a motion Sept. 14 to remove a federal judge from presiding over the case, according to The Hill

Advertisement

The defendants’ lawyers questioned if U.S. District Judge Dan Polster of Cleveland could remain impartial.

The lawyers accuse Mr. Polster of making improper comments about the opioid litigation to the media and in public forums. They also accuse him of prejudgement on the outcome of the trial and of focusing too heavily on settlement discussions.

The lawyers are requesting Mr. Polster to recuse himself from the trial, according to The Hill.

Lawyers for the plaintiffs said the motion is an attempt by the drug companies to avoid accountability for their role in fueling the opioid crisis.

Read the full article here.

More articles on opioids:

Historians request permanent, public archive of opioid litigation

AMA: 6 ways states can combat the opioid epidemic

Americans 7x more likely to fill opioid prescriptions than Swedes

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.